3,618 Shares in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Bought by Kraft Davis & Associates LLC

Kraft Davis & Associates LLC acquired a new stake in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) during the fourth quarter, HoldingsChannel reports. The fund acquired 3,618 shares of the company’s stock, valued at approximately $277,000.

Other institutional investors have also added to or reduced their stakes in the company. Financial Freedom LLC bought a new position in Invesco Pharmaceuticals ETF in the fourth quarter worth about $29,000. Comerica Bank purchased a new position in shares of Invesco Pharmaceuticals ETF in the 3rd quarter valued at approximately $33,000. ICA Group Wealth Management LLC bought a new stake in shares of Invesco Pharmaceuticals ETF during the fourth quarter valued at approximately $38,000. Credit Suisse AG purchased a new stake in Invesco Pharmaceuticals ETF in the second quarter worth $58,000. Finally, Horizon Bancorp Inc. IN bought a new position in Invesco Pharmaceuticals ETF in the third quarter worth $59,000.

Invesco Pharmaceuticals ETF Stock Up 1.0 %

Shares of PJP stock traded up $0.73 during mid-day trading on Friday, reaching $76.06. 11,635 shares of the company’s stock traded hands, compared to its average volume of 26,737. The company’s 50-day moving average price is $77.96 and its 200-day moving average price is $74.82. The company has a market cap of $266.96 million, a P/E ratio of 20.52 and a beta of 0.64. Invesco Pharmaceuticals ETF has a 12 month low of $67.75 and a 12 month high of $80.65.

Invesco Pharmaceuticals ETF Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.